An Ebola Vaccine that Seems to Work

Click For Summary
SUMMARY

An experimental Ebola vaccine has demonstrated 100 percent protection against the virus during trials conducted in the final stages of the West African epidemic. Although not yet approved by regulatory authorities, an emergency stockpile of 300,000 doses has been established for potential future outbreaks. The vaccine's effectiveness hinges on the distribution capabilities of government and public health officials, particularly in regions prone to Ebola. Experts emphasize the need for further research to develop vaccines that can protect against all Ebola strains and Marburg, while balancing acceptable risk levels for preventive use.

PREREQUISITES
  • Understanding of vaccine development processes
  • Knowledge of Ebola virus and its strains
  • Familiarity with public health distribution strategies
  • Awareness of the implications of vaccine side effects
NEXT STEPS
  • Research the latest developments in Ebola vaccine technology
  • Explore the concept of "ring vaccination" versus routine vaccination strategies
  • Investigate the role of emergency stockpiles in public health preparedness
  • Study the side effects associated with VSV-based vaccines
USEFUL FOR

Public health officials, vaccine researchers, epidemiologists, and anyone involved in infectious disease prevention and control will benefit from this discussion.

BillTre
Science Advisor
Gold Member
Messages
2,769
Reaction score
12,185
Lancet has a report of a vaccine for the Ebola virus.
 
  • Like
Likes   Reactions: atyy, jim mcnamara, Drakkith and 1 other person
Biology news on Phys.org
Here's a popular press summary of the article: http://www.nytimes.com/2016/12/22/health/ebola-vaccine.html

In a scientific triumph that will change the way the world fights a terrifying killer, an experimental Ebola vaccine tested on humans in the waning days of the West African epidemic has been shown to provide 100 percent protection against the lethal disease.

The vaccine has not yet been approved by any regulatory authority, but it is considered so effective that an emergency stockpile of 300,000 doses has already been created for use should an outbreak flare up again.
Seems like the vaccine should be very helpful in future outbreaks. However, it's efficacy will rely on the ability of government and public health officials to efficiently distribute the vaccine in future outbreaks, which is not always so easy in the third-world countries where Ebola outbreaks occur.

There is still work to do, however, to obtain better vaccines in the future:
An ideal vaccine would protect against all Ebola strains and Marburg. However, Dr. Kieny said, it may not be possible to make a shot effective against several strains if it is t based on the VSV spine because VSV triggers a lot of side effects.

Risks that are acceptable in the midst of a deadly epidemic are not acceptable in a preventive vaccine given to healthy children and adults, several experts noted.

Of course, it is not clear whether targeted, "ring vaccination" or routine vaccination would be the better strategy against a disease with relatively infrequent outbreaks such as Ebola.
 
  • Like
Likes   Reactions: atyy and BillTre

Similar threads

Replies
1
Views
2K
  • · Replies 2 ·
Replies
2
Views
3K
  • · Replies 20 ·
Replies
20
Views
3K
  • · Replies 7 ·
Replies
7
Views
3K
Replies
12
Views
2K
  • · Replies 61 ·
3
Replies
61
Views
5K
  • · Replies 1 ·
Replies
1
Views
2K
Replies
4
Views
3K
  • · Replies 9 ·
Replies
9
Views
2K
  • · Replies 3 ·
Replies
3
Views
2K